¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"back pressure renal atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pressure-cycled ventilator
    ¾Ð·ÂÁÖ±âÇüȯ±â±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
  • pressure-limited ventilator
    ¾Ð·ÂÁ¦ÇÑÇüȯ±â±â
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð, ÇãÆÄµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð, ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulse pressure
    ¸Æ¹Ú¾Ð, ¸Æ¾Ð
  • partial pressure
    ºÐ¾Ð
  • perfusion pressure
    °ü·ù¾Ð
  • resting blood pressure
    ¾ÈÁ¤Ç÷¾Ð
  • resting pressure
    È޽ıâ¾Ð·Â, ¾ÈÁ¤¾Ð·Â
  • saturation pressure
    Æ÷È­¾Ð·Â
  • saturation sound pressure level
    Æ÷È­¼Ò¸®¾Ð¼öÁØ, Æ÷È­À½¾Ð¼öÁØ
  • sound pressure
    ¼Ò¸®¾Ð, À½¾Ð
  • sound pressure level
    ¼Ò¸®¾Ð¼öÁØ, À½¾Ð¼öÁØ
  • static pressure
    Á¤Áö¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pressure-controlled ventilation
    ¾Ð·ÂÁ¶Àýȯ±â
  • pressure-limited ventilation
    ¾Ð·ÂÁ¦ÇÑȯ±â
  • pressure-perfusion study
    ¾Ð·Â°ü·ù°Ë»ç
  • pressure-preset ventilator
    ¾Ð·ÂÁ¦ÇÑÀΰøÈ£Èí±â
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð, Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulse pressure
    ¸Æ¹Ú¾Ð
  • resting blood pressure
    ¾ÈÁ¤Ç÷¾Ð
  • saturation pressure
    Æ÷È­¾Ð·Â
  • sound pressure
    À½¾Ð
  • static pressure
    Á¤¾Ð
  • sublimation pressure
    ½ÂÈ­¾Ð
  • systolic pressure
    ¼öÃà±â¾Ð
  • urethral pressure profile
    ¿äµµ³»¾Ð°î¼±
  • venous pressure
    Á¤¸Æ¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • renal arteriovenous fistula
    ½Åµ¿Á¤¸ÆÇǽºÅø¶ó, ½Åµ¿Á¤¸Æ·ç(ãìÔÑð¡Øæ×ª).
  • renal arteriovenous fistula
    ½Åµ¿Á¤¸ÆÇǽºÅø¶ó(ãìÔÑð¡Øæ¡­), ½Åµ¿Á¤¸Æ·ç(ãìÔÑð¡Øæ×ª)
  • renal artery
    ½ÅÀ嵿¸Æ, ½Åµ¿¸Æ, ÄáÆÏµ¿¸Æ.
  • renal artery
    ÄáÆÏµ¿¸Æ
  • renal artery
    ½Åµ¿¸Æ(ãìÔÑØæ)
  • renal artery embolism
    ½Åµ¿¸Æ»öÀü¼ú
  • renal artery stenosis
    ½Åµ¿¸ÆÇùÂø
  • renal artery,occlusion of
    ¡­ÀÇ Æó¼â(øÍáð)
  • renal artery,stenosis
    ½Åµ¿¸Æ ÇùÂø(ãìÔÑØæ úòó·)
  • renal asthma
    ½Å¼ºÃµ½Ä(ãìàõô·ãÓ).
  • renal asthma
    ½Å¼ºÃµ½Ä(¡­ô·ãÓ)
  • renal atheroembolic disease
    ½ÅÁ×»óÀü»öº´(ãìñÔßÚîûßáÜ»),½ÅÁ×Á¾»öÀüº´(ãìñÔðþßÝîûÜ»)
  • renal autonomic plexus
    ½Å ÀÚÀ²½Å°æÃÑ
  • renal autotransplantation
    ½Å ÀÚ°¡À̽Ä
  • renal azotemia
    ½Å¼º °íÁú¼ÒÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • basal blood pressure
    ±âÀúÇ÷¾Ð.
  • basal blood pressure
    ±âÀúÇ÷¾Ð(Ðìî¸úìäâ)
  • bite pressure
    ±³ÇÕ¾Ð(¡­äâ).
  • bite pressure impression
    ±³ÇÕ¾ÐÀλó.
  • biting pressure
    ±³ÇÕ¾Ð(Îáùêäâ).
  • bllod pressure
    Ç÷¾Ð(úìäâ)
  • blood pressure = BP
    Ç÷¾Ð(úìäâ)
  • blood pressure =BP
    Ç÷¾Ð(úìäâ).
  • blood pressure crisis
    Ç÷¾Ð¹ßÁõ(¡­Û¡ñø).
  • blood pressure cuff
    Ç÷¾Ð°è³¶´ë(úìäâͪҥÓá),Ç÷¾Ð ÃøÁ¤¿ë Ä¿ÇÁ(úìäâö´ïÒéÄ- ).
  • blood pressure cuff
    Ç÷¾Ð°è³¶´ë.
  • blood pressure fluctuation
    Ç÷¾Ð µ¿¿ä(úìäâÔÑèô).
  • blood pressure fluctuation
    Ç÷¾Ðµ¿¿ä (¡­ÔÑèô).
  • blood pressure manometer
    Ç÷¾Ð°è(úìäâͪ).
  • blood pressure manometer
    ÀÇ,¸¶ÃëÇ÷¾Ð°è(¡­Íª).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PSMA proximal spinal muscular atrophy
SBMA spinal bulbar muscular atrophy
SMA sequential multiple analysis or analyzer; sequential multichannel autoanalyzer; simultaneous multich...
SPMA spinal progressive muscular atrophy
STVA subtotal villose atrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
RFR Renal functional reserve
RHR Renal hypertensive rats
RI Renal insufficiency
RIF Renal interstitial fluid
RNA Renal nerve activity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal surgery
    ½ÅÀå ¼ö¼ú
  • renal teratoma
    ½Å ±âÇüÁ¾
  • renal thyroidization
    ½ÅÀÇ °©»ó¼±È­
  • renal transplantation
    ½Å À̽Ä
  • renal tuberculosis
    ½Å °áÇÙ
  • renal tubular secretion
    ½Å ¼¼´¢°ü ºÐºñ
  • renal tuburlar acidosis
    ½Å ¼¼´¢°ü »êÁõ
  • renal tumor
    ½Å Á¾¾ç
  • renal uremia
    ½Å¼º ¿äµ¶Áõ
  • renal vascular injury
    ½Å Ç÷°ü ¼Õ»ó
  • renal vein
    ½Å Á¤¸Æ
  • renal vein thrombosis
    ½Å Á¤¸Æ Ç÷ÀüÁõ
  • renal venography
    ½Å Á¤¸Æ Á¶¿µ¼ú
  • renal vessel
    ½Å Ç÷°ü
  • selected renal arteriography
    ¼±ÅÃÀû ½Åµ¿¸Æ Á¶¿µ¹ý
    ´ëÅ𠵿¸Æ¿¡¼­ Ä«Å×Å͸¦ »ðÀÔÇØ Åõ½ÃÇÏ¿¡¼­ ¼±ÅÃÀûÀ¸·Î ½Åµ¿¸Æ¿¡ Á¶¿µÁ¦¸¦ ÁÖÀÔÇÏ´Â ¹æ¹ý.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
renal agenesis <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
renal amyloidosis Renal deposits of amyloid, especially in glomerular capillary walls, which may cause albuminuria and the nephrotic syndrome.
Synonym: amyloid nephrosis.
(05 Mar 2000)
renal artery <anatomy, artery> A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á